Vaxcyte, Inc. · NASDAQ:PCVX
Wassil Jim sold 2,250 Vaxcyte, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Wassil Jim (EVP, Chief Scientific Ofc, COO) sold 2,250 Vaxcyte, Inc. shares at an average US$60.90 for US$137K under a trading plan, leaving 145,435 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 2,250 shares
- Price
- US$60.90 average (US$60.78 to US$61.57)
- Value
- US$137K
- Holding after
- 145,435 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Scientific Ofc, COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Option exercise | 2,250 | US$5.35 | 147,685 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,907 | US$60.78 | 145,778 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 343 | US$61.57 | 145,435 | Direct |
Source
Download original · View original at SEC
Related
- Vaxcyte, Inc.
- Wassil Jim
- Vaxcyte, Inc. shareholders
- Form 4 · Wassil Jim · Oct 7, 2026
- Form 4 · Wassil Jim · Oct 2, 2026
- Form 4 · Wassil Jim · Sep 9, 2026
- Form 4 · Wassil Jim · Sep 2, 2026
- Form 4 · Wassil Jim · Aug 5, 2026
- Schedule 13G · Wellington Management Group LLP · Nov 16, 2026
- Form 4 · Dhaliwal Harpreet S. · Nov 13, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Form 4 · Cowan Elvia · Nov 4, 2026